CT1195E
/ Institute of Hematology and Blood Diseases Hospital, CARsgen
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
January 22, 2026
Safety, Efficacy and Cellular Metabolic Dynamics of CT1195E in Patients With Refractory / Progressive SSC
(clinicaltrials.gov)
- P1 | N=12 | Recruiting | Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
New P1 trial • Immunology • Scleroderma • Systemic Sclerosis
1 to 1
Of
1
Go to page
1